Vogenx, Inc. filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the fiscal quarter ended September 30, 2026, its first such filing as a public company subject to Exchange Act reporting requirements.

Key Highlights

  • Share count: As of November 5, 2026, Vogenx had 14,855,087 shares of common stock, par value $0.0001 per share, outstanding.
  • Exchange listing: Common stock trades on The Nasdaq Capital Market under the symbol VOGX (NASDAQ:VOGX).
  • Filing status: The registrant indicated it has NOT filed all reports required during the preceding 12 months, checking "No" on the timely-filing compliance checkbox.
  • Company classification: Vogenx is classified as a non-accelerated filer, smaller reporting company, and emerging growth company.
  • Shell company status: The registrant indicated it is not a shell company as defined in Rule 12b-2 of the Exchange Act.
  • Incorporation: Vogenx is incorporated in Delaware, with an I.R.S. Employer Identification Number of 86-3697324, and is headquartered in Raleigh, North Carolina.

Vogenx's Quarterly Disclosure: Company Status, Share Count, and Filing Background

Vogenx, Inc. (NASDAQ:VOGX), a Delaware-incorporated company based in Raleigh, North Carolina, submitted its Form 10-Q for the quarterly period ended September 30, 2026, filed November 6, 2026. The cover page of the filing discloses a Commission File Number of 001-43441 and identifies the company's principal executive offices at PO Box 19469, Raleigh, North Carolina 27619. As of November 5, 2026, the registrant reported 14,855,087 shares of common stock outstanding at a par value of $0.0001 per share.

According to the filing, Vogenx checked "No" when asked whether it has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, or for such shorter period that the registrant was required to file. The company did confirm that it has submitted electronically every Interactive Data File required under Rule 405 of Regulation S-T. The registrant is classified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, and it has not elected to use the extended transition period for complying with new or revised financial accounting standards.

The filing contains forward-looking statements, which the company's own cautionary language describes as subject to known and unknown risks, uncertainties, and other factors that "may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements." Topics addressed in those forward-looking statements include clinical trial timing and progress, product candidate development, capital requirements, and regulatory developments, among others listed in the filing.

What Was Disclosed

Vogenx filed a Form 10-Q for the quarter ended September 30, 2026, disclosing 14,855,087 shares of common stock outstanding as of November 5, 2026, its Nasdaq Capital Market listing under VOGX, and its status as an emerging growth company and smaller reporting company.